Skip to content

Our initiatives advance treatments for patients of all ages across brain tumor types.

Uniquely poised to drive change and progress throughout the drug discovery and development pipeline, our initiatives and programs further knowledge and deliver results to our community.

DNA Damage Response (DDR) Consortium

Our flagship research initiative, the DDR Consortium, brings together a diverse team of renowned adult and pediatric researchers to rapidly advance a new class of promising potential treatments.

See All News

Stay Informed & Connected